DACH
EQT to sell Utimaco majority stake to SGT Capital
EQT will retain a minority stake in the Germany-based cybersecurity firm, which it acquired in 2016
L Catterton et al. in EUR 100m round for SellerX
SellerX has already raised amost EUR 250m in debt and equity in its 12 months since inception
Gyrus closes Investment Programme on EUR 430m
Gyrus expects the funds to be fully deployed within 12 months, with a new fundraise in 2022
General Atlantic leads EUR 100m Series C for Chrono24
Aglaé Ventures, Insight Partners and Sprints Capital also take part
HQ Equita buys Indevis
GP is currently investing via Equita V, which held a final close in April 2019 on EUR 308m
Permira buys brokerage platform Engel & Völkers
Deal continues a hot 2021 streak for the GP, with seven deals on the buy-side so far
The Deals Pipeline
A highlight of deal processes underway and involving PE, either on the buy- or sell-side, across Europe
FSN secures majority stake in Adragos Pharma
Deal is the fourth investment from FSN Capital VI, which closed on EUR 1.8bn in June last year
Astorg acquires surgery supplies manufacturer Demetra
Keensight merged medical technology businesses Tecres and Aap Biomaterials to form Demetra in 2016
Secondaries activity rebounds to record USD 55bn in H1 – survey
Direct secondaries account for the majority of transactions for the first time ever, says Setter Capital
Houlihan Lokey to buy GCA
GCA Altium and GCA’s US business will operate under the Houlihan Lokey brand
Ambienta sells Calucem to Cementos Molins in EUR 150m deal
Calucem reports a turnover of EUR 58m, with an EBITDA of EUR 16m
Bregal Milestone to launch second fund
European growth technology investor held a final close for its debut vehicle in 2018 on EUR 400m
Tiger Global leads USD 175m round for Contentful
Berlin-headquartered mobile application and digital content developer is valued at USD 3bn
Afinum, SHS sell Evitria to trade
Exit values the Switzerland-based antibody expression specialist at more than EUR 200m
Capiton raises top-up single asset fund for KD Pharma
GP completed its first single-asset deal for KD Pharma in 2019, having acquired the company in 2013
Bregal acquires Advent-backed Laird Thermal Systems
Advent acquired LTS's parent company Laird in a GBP 1.2bn take-private in 2018
Mega-rounds fuel record H1 for venture and growth
Largest rounds inked in the first six months of 2021 read like a veritable Who's Who of European fintech heavyweights
Tikehau holds EUR 617m final close for European Special Opportunities II
Fund surpassed its EUR 500m target and is more than 50% deployed, with a 68% re-up rate
Trilantic invests in Smile Eyes
Trilantic intends to pursue a buy-and-build strategy for the German ophthalmology clinic chain
The Deals Pipeline
A highlight of deal processes underway and involving PE, either on the buy- or sell-side, across Europe
Bayer ESP eyed by Bain, Cinven ahead of post-summer sale launch
Bayer could expect to fetch in excess of EUR 2bn for ESP, two sources say
Eurazeo Growth III holds final close on EUR 1.6bn
Vehicle surpassed its EUR 1bn target and will provide initial equity tickets of EUR 25m-100m
PE buy-side appetite further boosts exit options for sponsors
Secondary buyouts accounted for nearly a third of all PE exits in the first half of 2021, compared with typical levels of 20-25%